Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
NCT01915511
This study is recruiting at 39 US sites in 24 states, according to its ClinicalTrials.gov record last updated .
Summary
The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the registry expanded to include recruitment of participants with other chronic fibrosing interstitial lung diseases (ILDs) with progressive phenotype also referred to as progressive fibrosing interstitial lung diseases in the Chronic Fibrosis Interstitial Lung Disease with Progressive Phenotype (ILD-PRO) Registry.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Duke University
- Last updated on ClinicalTrials.gov
- August 12, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama - Birmingham · Birmingham, AL
Arizona · 1
- University of Arizona · Tucson, AZ
California · 3
- University of California - Los Angeles · Los Angeles, CA
- University of Southern California · Los Angeles, CA
- Stanford University · Stanford, CA
Colorado · 1
- University of Colorado · Aurora, CO
Connecticut · 1
- Yale University · New Haven, CT
Florida · 2
- University of Florida · Gainesville, FL
- University of South Florida · Tampa, FL
Georgia · 2
- Emory University · Atlanta, GA
- Piedmont Healthcare · Austell, GA
Illinois · 3
- University of Chicago · Chicago, IL
- Northwestern University · Evanston, IL
- Loyola University Health System · Maywood, IL
Louisiana · 1
- Tulane University · New Orleans, LA
Michigan · 1
- Henry Ford Health · Detroit, MI
Minnesota · 1
- University of Minnesota · Minneapolis, MN
Mississippi · 1
- University of Mississippi Medical Center · Jackson, MS
Missouri · 1
- Washington University · St Louis, MO
New York · 1
- Weill Medical College of Cornell University · New York, NY
North Carolina · 4
- UNC Chapel Hill · Chapel Hill, NC
- Duke University · Durham, NC
- Pulmonix LLC · Greensboro, NC
- Wake Forest Baptist Health · Winston-Salem, NC
Ohio · 2
- Cleveland Clinic · Cleveland, OH
- The Ohio State University · Columbus, OH
Oklahoma · 1
- University of Oklahoma · Oklahoma City, OK
Oregon · 1
- Oregon Clinic · Portland, OR
Pennsylvania · 2
- Temple University · Philadelphia, PA
- Thomas Jefferson University · Philadelphia, PA
South Carolina · 1
- Medical University of South Carolina · Charleston, SC
Tennessee · 1
- Vanderbilt University · Nashville, TN
Texas · 5
- Baylor University Medical Center at Dallas · Dallas, TX
- University of Texas Southwestern · Dallas, TX
- Baylor College of Medicine · Houston, TX
- Houston Methodist Lung Center · Houston, TX
- The University of Texas Health Science Center At Houston · Houston, TX
Utah · 1
- University of Utah · Salt Lake City, UT
Virginia · 1
- Inova · Falls Church, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.